CONMED Corporation

Historical 13F Holders

Symbol
CNMD
CUSIP
207410101
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 207410101 since 12/18/2024, newest first.

Filer % of Class Filed
Fuller & Thaler Asset Management, Inc. 13G/A Amendment 1 4.9% 11/16/2026
Event 9/30/2026
Vanguard Portfolio Management LLC 13G 6.9% 4/29/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.3% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 14 0% 3/26/2026
Event 3/13/2026
Capital Research Global Investors 13G/A Amendment 3 3.3% 11/13/2025
Event 9/30/2025
Fuller & Thaler Asset Management, Inc. 13G 5.6% 8/14/2025
Event 6/30/2025
BlackRock, Inc. 13G/A Amendment 20 15.1% 7/18/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 271 34.0 M $1.57B
2026 Q2 248 34.1 M $1.12B
2026 Q1 239 34.1 M $1.21B
2025 Q4 269 34.0 M $1.38B
2025 Q3 277 34.6 M $1.63B
2025 Q2 283 35.0 M $1.82B
2025 Q1 285 35.6 M $2.15B
2024 Q4 282 35.8 M $2.45B
2024 Q3 293 33.9 M $2.44B
2024 Q2 294 35.7 M $2.48B
2024 Q1 301 35.6 M $2.85B
2023 Q4 308 36.1 M $3.96B
2023 Q3 278 35.6 M $3.59B
2023 Q2 264 35.3 M $4.80B
2023 Q1 234 36.3 M $3.77B
2022 Q4 241 35.8 M $3.17B
2022 Q3 255 34.9 M $2.80B
2022 Q2 282 33.9 M $3.25B
2022 Q1 281 32.3 M $4.79B
2021 Q4 267 32.2 M $4.56B
2021 Q3 262 31.5 M $4.13B
2021 Q2 254 31.4 M $4.32B
2021 Q1 241 31.0 M $4.05B
2020 Q4 250 30.8 M $3.46B
2020 Q3 243 30.3 M $2.38B
2020 Q2 230 29.6 M $2.13B
2020 Q1 231 29.5 M $1.69B
2019 Q4 264 29.2 M $3.27B
2019 Q3 238 29.2 M $2.80B
2019 Q2 230 29.3 M $2.50B
2019 Q1 229 29.1 M $2.42B
2018 Q4 208 27.2 M $1.75B
2018 Q3 209 27.6 M $2.19B
2018 Q2 197 27.7 M $2.03B
2018 Q1 175 27.3 M $1.73B
2017 Q4 160 27.9 M $1.42B
2017 Q3 146 28.1 M $1.47B
2017 Q2 151 27.8 M $1.42B
2017 Q1 145 28.1 M $1.25B
2016 Q4 148 28.0 M $1.24B
2016 Q3 148 28.3 M $1.13B
2016 Q2 157 28.2 M $1.35B
2016 Q1 160 27.7 M $1.16B
2015 Q4 154 27.5 M $1.21B
2015 Q3 159 27.5 M $1.31B
2015 Q2 157 27.2 M $1.58B
2015 Q1 148 26.9 M $1.36B
2014 Q4 157 26.3 M $1.18B
2014 Q3 165 23.9 M $881M
2014 Q2 181 23.7 M $1.04B
2014 Q1 173 24.7 M $1.07B